Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study
- DOI
- 10.3389/fendo.2026.1855886
- Published
- 2026-07-06
- Container
- Frontiers in Endocrinology
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fendo.2026.1855886,
title = {Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study},
author = {Martina Galasso and Ludovica Verde and Renato Patrone and Giovanni Ragozzino and Giuseppe Annunziata and Annamaria Colao and Luigi Barrea and Giovanna Muscogiuri},
year = {2026},
journal = {Frontiers in Endocrinology},
doi = {10.3389/fendo.2026.1855886},
url = {https://doi.org/10.3389/fendo.2026.1855886}
}RIS
TY - JOUR TI - Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study AU - Martina Galasso AU - Ludovica Verde AU - Renato Patrone AU - Giovanni Ragozzino AU - Giuseppe Annunziata AU - Annamaria Colao AU - Luigi Barrea AU - Giovanna Muscogiuri PY - 2026 JO - Frontiers in Endocrinology DO - 10.3389/fendo.2026.1855886 UR - https://doi.org/10.3389/fendo.2026.1855886 ER -
APA
Galasso, M., Verde, L., Patrone, R., Ragozzino, G., Annunziata, G., Colao, A., Barrea, L., & Muscogiuri, G. (2026). Tirzepatide and metabolic dysfunction-associated steatotic liver disease (MASLD) in obesity: a real-world multicenter study. Frontiers in Endocrinology. https://doi.org/10.3389/fendo.2026.1855886
Source records
- crossref · retrieved 2026-09-25T18:22:18.388Z